{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-69",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-69.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "regulation/69",
  "kind": "regulation",
  "number": "69",
  "heading": "Local dispute resolution before serving remedial notices or breach notices",
  "text": "(1) Subject to paragraph (3), before issuing a notice under regulation 70 or 71, NHS England must make every reasonable effort to communicate and co-operate with an NHS chemist (C) with a view to resolving any dispute between C and NHS England relating to C's compliance with C's terms of service.\n(2) Where an NHS pharmacist invites a Local Pharmaceutical Committee to participate in the attempts to resolve the dispute, NHS England must make every reasonable effort to communicate and co-operate with the Committee in its attempts to assist in resolving the dispute.\n(3) Paragraphs (1) and (2) do not apply where NHS England is satisfied—\n(a) the dispute relates to a matter that has already been the subject of dispute resolution between NHS England (or a Primary Care Trust) and C and there are no new issues of substance that justify delay in issuing a notice under regulation 70 or 71; ...\n(aa) C is in breach of C’s obligation under regulation 68(1) in relation to the dispute; or\n(b) that it is appropriate to proceed immediately to issuing a notice under regulation 70 or 71—\n(i) because listed chemist premises are not, or have not been, open during core opening hours or supplementary opening hours without good cause , NHS England having made reasonable efforts to communicate with C with a view to establishing what the cause was,\n(ii) to protect the safety of any persons to whom C may provide pharmaceutical services, or\n(iii) to protect NHS England from material financial loss.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Word in reg. 69(3)(a) omitted (1.10.2026) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 8(2)(a)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Reg. 69(3)(aa) inserted (1.10.2026) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 8(2)(b)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in reg. 69(3)(b)(i) inserted (26.11.2018) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2018 (S.I. 2018/1114), regs. 1(1), 3(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/regulation/69",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}